20 Burst results for "Bio Intech"

"bio intech" Discussed on TIME's Top Stories

TIME's Top Stories

03:54 min | Last week

"bio intech" Discussed on TIME's Top Stories

"Or less search turbotax tips. Wherever you listen to podcasts. They top official has admitted that chinese vaccines have low effectiveness by joe mcdonald and we'd song woo beijing in a rare admission of the weakness of chinese corona virus. Vaccines the country's top disease. Control officials says their effectiveness is low and the government is considering mixing them to get a boost. Chinese vaccines don't have very high protection. Rates said the director of the china centers for disease control gal food at a conference saturday. In the southwestern city of chengdu beijing has distributed hundreds of millions of doses abroad while trying to promote doubt about the effectiveness of the pfizer biotech vaccine made using the previously experimental messenger or are in a process. It's now under formal consideration whether we should use different vaccines from different technical lines for the immunization process gal said officials at a news conference. Sunday didn't respond directly to questions about gals comment or possible changes and official plans but another. Cdc officials said developers are working on ima- rene based vaccines dow did not respond to a phone call requesting further comment the mri vaccines developed in. Our country have also entered. The clinical trial stage said the official wong watching. He gave no timeline for possible. Use experts say mixing vaccines or sequential. Immunization might boost effectiveness. Researchers in britain are studying possible combination of pfizer bio intech and the traditional astrazeneca vaccine the coronavirus pandemic which began in central china in late. Two thousand nineteen marks the first time. The chinese drug industry has played a role in responding to a global health. Emergency vaccines made by sign. Afaq a private company and sino-pharm a state owned firm have made up the majority of chinese vaccines distributed to several dozen countries including mexico turkey indonesia hungary and brazil. The effectiveness of a sign of vaccine at preventing symptomatic infections was found to be as low as fifty point four percent by researchers in brazil nearly fifty percent threshold at which health experts say. A vaccine is useful by comparison. The pfizer bio intech vaccine has been found to beat ninety seven percent effective health. Experts say chinese vaccines are unlikely to be sold in the united states western europe and japan due to the complexity of the approval process. A sivak spokesman lee pay chung acknowledged varying levels of effectiveness have been found but said that can be due to the age of people in the study. The strain of virus and other factors. Beijing has yet to approve any foreign vaccines for use in china. Gal gave no details of possible changes and strategy but cited ima- a as a possibility. Everyone should consider the benefits in in a vaccines can bring for humanity. Gal said we must follow it carefully and not ignore it just because we already have several types vaccine's already gal previously questioned the safety of m. r. a. vaccines. He was quoted by the official xinhua news agency as saying in december. He couldn't rule out negative side effects because they were being used for the first time on healthy people. Chinese state media and popular health and science blogs also have questioned the safety and effectiveness of the pfizer by you in tech scene as of april second. Some thirty four million people in china have received both of the two doses required for chinese vaccines and about sixty five million received one. According to gal the sign of spokesman lee you said studies find protection. May be better if time between vaccinations is longer than the current fourteen days but gave no indication that might be made standard practice..

joe mcdonald december ninety seven percent saturday brazil united states two doses Gal sino-pharm indonesia Sunday mexico one april second turkey fourteen days japan about sixty five million chengdu Cdc
"bio intech" Discussed on Intelligence Squared U.S. Debates

Intelligence Squared U.S. Debates

07:02 min | Last week

"bio intech" Discussed on Intelligence Squared U.S. Debates

"The risk is actually taken on by the by the public because so much Investment was made by public into product development and clinical trials and then once the products come to market. We know that this is likely to be. And is already proven to be a very lucrative market where the companies are more than earning back those additional research dollars that they put in so for example modern it is projected to make eighteen billion dollars this year from its sales visor and biontech working in partnership are expecting sales between fifteen billion thirty billion dollars and then we have johnson and johnson and then we have astrazeneca. We have novak's we have other vaccines that are coming on board as well. Not not to mention. The chinese and russian vaccine says well there are lots of lots of money to be made and we know that some of the prices are quite high. We know for example that the biontech product is nine hundred dollars and fifty cents per dose thirty nine dollars for for course vaccination And there are estimates that the cost of production is much much lower than that dispute about how much it is but One one university group it said could be two three dollars the undisclosed profit price that pfizer has promised in negotiation with kovacs Are estimated between six and seven dollars and so there are significant markups in the in the already in also i would mention which spicer said which is once they get beyond the pandemic Acute phase in the us and europe. They may well raise their backseat price. To as much as one hundred fifty or one hundred seventy five dollars. Let me take it back to thomas than the part of your argument that i'd like to hear your response to thomas is The argument that because public money was involved in the development of these vaccines that the the notion that the companies therefore get to own the patents fully an outright and to earn whatever profits. Come their way is not justified in this particular case. So this is separate from the issue of the degree of the emergency out there but just the structure of the deal. Let's put it that way. that there seems to be something unfair or unjust about the company's having the ability to benefit fully from the sales when the investment was not fully. There's but you response to that the chew adams which we really need to bear in mind here on the one hand the head impact millions of lives lost because of covid nineteen Huge economic impact. The imf chief economist estimated to cost of pandemic at free hundred and seventy five billion dollars per month. Many look at the back stains impact back sins effectiveness in terms of return on investment. I think this is probably the best public health. Investment world sever ask therefore you really need to compare the cost of dynamic with high watch benefit from having backseats having said that dean's Early onset is is not businesses usually ivy cooler year Beinart could stated travel. I came to your can dive onto the get vaccinated against shingles because vaccine is not yet available in my country i painted by fiance dollars for a shingles vaccination and you need to those here. We talk about you know on the higher end of the nineteen to twenty dollars per those we talk about the oil companies offering low crisis for this curve x partnership countries in the world. And then you look at the investment in these accents it's really. It's a fraction. Compared to the benefit we get seeing the light at the end of the tunnel of the economic impact. But i think something is. Research needs to be bowling. Mind one is modano. Biontech are not the same as faisal faisal. For example publicly said from the beginning we do not want all the money to asterisk to head We invest three sky says but at the same time they will commit to sending the back since socially responsible christ when you look at vice star compared to It hasn't benefited from deir huge success. Who is expected ninety five percents vacancy of covid nineteen vaccine on top of vase. Safe by Not today from ballgame because until twenty nine thousand nine hundred. Snow looked at the annual reports of birth of the companies. You had lots of frisks you had tries and you didn't have seamless Yet from down on bio intech. Day disservices Year investments in technology. Which is ready to become a game changer for all of us and we usually impactful fulfilled to endemic preparedness. If he don't take the incentives way which made those sponsor false brook tiana respond again. The evidence is that a great deal of the imaginary technology Background scientific research was funded by the nih. And and and again yes which is true of which is true of not just this vaccine but is that academic And government investment in research is is often something that ultimately is fed into the development of pharmaceutical products. Certainly i mean that's the basic scientific research but this was specific investments in the minority technology platform in part because many of the major companies had walked away from vaccines. They start. there's certainly coming back and some of them are running back right now but also there are some of the more expensive axes like the shingles vaccine and a couple of others that initially attractive to companies. I guess i want to the Hop back on on. Maybe a couple a couple issues. I think i think one of the things that thomas and i would disagree with is is is the industry Justified in giving such preferential access to rich countries so to me there are three problems with with the ip system that we allowed to continue and for folks to understand ip system. You're referring to intellectual property. Intellectual property were right which would be patents and trade secrets just pans but also trade secrets and that it does get the that the limbic supply. Now i agree with. Thomas has been investments and contract manufacturing. And there's more supply than.

fifty cents nine hundred dollars eighteen billion dollars thomas hundred thirty nine dollars nineteen one hundred seventy five dolla Thomas one hundred fifty johnson europe ninety five percents seven dollars fifteen billion thirty billion nineteen vaccine this year pfizer three problems russian
"bio intech" Discussed on TIME's Top Stories

TIME's Top Stories

03:37 min | 3 weeks ago

"bio intech" Discussed on TIME's Top Stories

"Don't get asked with cova older teens and adults do how these children's immune system's response to the virus and the vaccine remains a black box. The trial will also help. Provide some clarity on those questions visor. Bioenergy says it will test the same vaccine that is currently authorized for emergency use in the us for those sixteen years and older but this time in children aged six months to eleven years. The company is currently wrapping up. Study of its to dose shot in adolescence aged twelve to fifteen years in the us and europe. The latest pediatric trial will follow the same at three phased approach as adult study with phase. One involving one hundred forty. Four children aged five to eleven years at duke boston children's hospital. Cincinnati children's hospital and johns hopkins. Who will all receive the vaccine but be randomly assigned one of three dosages. If the vaccine is safe in this age group children aged two to four years will be tested and if safe in that group. The youngest children from six months to two years will get the vaccine. Depending on the immune responses these children generate the scientists adviser bio intech will make a decision about the safest and most effective dose with which to proceed in. Its face to face phase three studies. Those will include a total of about forty five hundred children. Broken down in the same age categories this time randomly assigned to receive either the vaccine or placebo in a two to one ratio. The results will be analyzed after six months to determine if the children receiving the vaccine both generated a stronger immune response than those getting placebo and that the response was on par with responses vaccinated adults. If that's the case then finds her bio intech will submit the data to the us food and drug administration to expand authorization to younger children and hopefully start vaccinating them by early next year. Dr manual walter professor of pediatrics and chief medical officer at the human vaccine institute who has overseeing the trial there says the study will answer important questions about the safety and dosing of the vaccine for children specifically whether younger children will need a different dose than adolescents and adults. The trial will test dose about one third that of the current adult dose another. That is about half the adult dose as well as the adult does while the pfizer bio tech covid. Nineteen shot is the. I m are innate technology based vaccine of any kind to gain fda authorization. Walter says it's likely to be safe in children. I don't think it's the platform so much that i would worry about for young children. I feel comfortable. Giving the ima- rene to young children. The questions of will they have side effects. Will the vaccine be tolerable to children and do. We need to use a smaller dose. In young kids are the biggest things so far. Walter says that they have seen an overwhelming response to the pediatric trial with parents. Like the gerardo expressing interest in enrolling their children both gerardo and his wife who is an infectious disease physician at duke are vaccinated and he says before his daughter is joined the trial they discussed volunteering with the girls. They understand that the results are going to impact other kids. And that's one of the lessons. We want to teach them with this experience. He says that this was one of the ways to contribute to help other people..

Walter sixteen years Nineteen shot six months two years one europe four years eleven years early next year one hundred forty about forty five hundred child children's hospital gerardo three dosages Four children johns hopkins both fifteen years One
"bio intech" Discussed on People's Pharmacy

People's Pharmacy

05:35 min | Last month

"bio intech" Discussed on People's Pharmacy

"The first time in a year. We are hopeful. The end of the pandemic is incite. But are we prepared for the next one. This is the people's pharmacy with terry and joe graydon infections that don't respond to antimicrobial. Treatment are already becoming more common. What will doctors do when the antibiotics antifungal drugs. They've relied upon for decades stop. Working hospitals are among the most secretive organizations in the country. Trying to figure out the true cost of treatment is extremely challenging. Prescription drugs have become budget-busters. What can we do to reverse this. Trend coming up on. The people's pharmacy could antimicrobial resistant. Infections become the next and dynamic in the people's pharmacy health headlines public health experts have been worried about the evolution of sars covy to the corona virus responsible for covid nineteen some of the new variants. That have arisen may have the potential to be transmitted more easily that appears to be the case with be one one seven a variant. I identified in the uk. Researchers in great britain looked at genomes from over at thousand kovic positive nasal swabs and found that most people had only one or two variants but a few had numerous mutated viral genomes mutations in the spike protein have scientists concerned because they could help the virus the immune system the variant called p. one first detected in brazil is worrisome. In this regard a report published in the new england journal of medicine has a laid some fears according to the manufacturers the pfizer bio intech vaccine is effective against p. one in laboratory tests the researchers used serum from vaccinated volunteers and found that it neutralized the virus. A small study published last november in jama disappeared almost without a trace it compared fluvoxamine to placebo for treating cova patients. The results were surprisingly good. Out of one hundred and fifty two people with covid nineteen eighty took fluvoxamine and seventy two took a look alike placebo pill. Six of those on placebo had serious clinical deterioration. Compared to none of those on fluvoxamine this study is being replicated in a larger trial to confirm whether fluvoxamine has significant benefits against covid this generic medicine is prescribed primarily to treat obsessive compulsive disorder..

Six brazil last november uk first time nineteen eighty two variants nineteen seventy two fluvoxamine one first one hundred and fifty two peop england britain pfizer thousand p. one
"bio intech" Discussed on TIME's Top Stories

TIME's Top Stories

06:03 min | Last month

"bio intech" Discussed on TIME's Top Stories

"Has three safe and effective covid nineteen vaccines being shipped around the country and making it into people's arms all meet the us food and drug administration's threshold for protecting people from cova nineteen disease yet. Two of them are about ninety. Five percent efficacious while another is sixty six percent efficacious. Which may make tempting to rank them and assume that people receiving the sixty six percent efficacious shot are somehow less protected against covid nineteen. That's not the case however since it's not really possible to compare the vaccines to each other to start. There's a difference between efficacy and effectiveness. Efficacy refers to the results for how well a drug or vaccine works based on testing while effectiveness refers to how well these products work in the real world and a much larger of people most people however use them interchangeably. Next it's important to understand what these companies were actually measuring to come up with their efficacy numbers and the case of the covid nineteen vaccines. The researchers were measuring. How well they're vaccines protected against symptoms of covid nineteen. So they're vaccine efficacy numbers referred to how well they lowered people's chance of getting sick with covid nineteen pfizer by owen. Tech's vaccine is ninety. Five percent efficacious meaning that four vaccinated people it was ninety five percent efficacious and protecting people from getting covid nineteen symptoms. It does not mean that ninety five percent of people vaccinated won't get covid nineteen and five percent will similarly maderna's vaccine is ninety four percent efficacious. So it was ninety four percent efficacious in protecting people from covid nineteen and johnson. And johnson's vaccine is sixty six percent efficacious in doing the same. But that doesn't tell the whole story for a few reasons. First the vaccines work in different ways. Visor bio intech and madonna developed their vaccines using 'em in a technology which involves taking the genetic code for the spike protein of the sars covy to virus and encasing it in a fat based particle that is injected into the body once inside sales those viral genes instruct immune cells to produce copies of the protein which in turn switches the immune system. Interaction churning out sells like antibodies among other activities if the vaccinated person then gets infected with the actual virus. The body is ready to quickly. Produce those same antibodies that can stick to the virus and block it from infecting cells. Johnson and johnson janssen's vaccine uses a different strategy a weakened cold virus that has reprograms to include the code for the spike protein. Once inside the body the viral genes trigger a similar dedicated response against the virus because vaccines use different ways. To alert the immune system. The differing technologies could lead to varying degrees of efficacy second each vaccine has different dosing. Regimens visor bio intex and modernise shots require two doses in pfizer bio intex case. The two shots are one days apart. And in maderna's case they are twenty eight days apart. Janssen's vaccine is a single shot. Pfizer bio intech and madonna say. Their shots can stimulate the immune system after a single dose. But the second dose is needed to trigger the maximum response. Janssen's scientists are also testing a booster dose of their vaccine to see if it to might amplify the immune response third the vaccine companies started recording covid nineteen symptoms at different times after vaccination to see how well their shots could prevent disease and their respective late stage studies visor bio intech started recording symptoms seven days after people received the second shot of its vaccine or placebo. Madonna started fourteen days after the second dose and jansen recorded results from both fourteen days in twenty eight days after it single dose for the vaccines were tested at different times. that's important because of the genetic variants of the virus some of which are more infectious than the original that have emerged in recent months after some companies had already completed initial testing of their vaccines visor bio intech and modern up. Both tested their shots through most of twenty twenty. When sars cov two had not mutated as much so most of the study participants who are infected. Were infected by the same viral strain. Johnson however started its large phase three trial in september and included people in the uk south africa and brazil the three countries where new mutated variants of the virus started to spread quickly. Indeed many of the people in janssen's trial in those countries were infected with the new variants from a scientific point of view that means janssen study provided important clues about how well its vaccine could confront the growing threat of new variants of the virus. That could also explain why the janssen vaccine's efficacy is lower than those of the pfizer bio intech and maternal shots. In fact studies have since shown that among people vaccinated with pfizer biontech and moderna vaccines level of antibodies against the south african. Variant in particular are up to sixfold lower compared to levels against the non mutated virus. So for all of these reasons comparing the three vaccines is a bit like comparing apples to oranges. What's important is that all fight covid. Nineteen according to the fda's standard of efficacy. Which is that vaccines should be. At least fifty percent efficacious and protecting people from disease and all are extremely effective in protecting people from getting severely ill willed or dying from nineteen which ultimately is what we'd won't any vaccine to do..

johnson uk ninety brazil Johnson ninety five percent ninety four percent sixty six percent five percent Two three countries september Nineteen two shots second dose Madonna south african second shot south africa each vaccine
"bio intech" Discussed on TIME's Top Stories

TIME's Top Stories

05:24 min | 2 months ago

"bio intech" Discussed on TIME's Top Stories

"Andy slamet senior adviser the white house cova nineteen response team and jeff zion's white house covid nineteen response coordinator. The group provided updates on the state of the vaccine rollout would slap at noting that the scientists voucher will and nunez smith intentionally provided updates on the data and science of emerging mutant viruses. I it was just refreshing to have a press conference in which the discussion was based on evidence. And we didn't hear any outrageous things says dr carlos del rio executive associate dean of emory school of medicine who listens to the briefing. During his presentation slavic noted that the biden administration did not inherit a fully developed strategy or infrastructure to make vaccines readily available to americans as quickly as they need to be. That's already changing. He sat as this week. Thanks to the team's new actions the federal government shipped one million vaccines on average a day. The necessary target to meet the president's goal of vaccinating one hundred million people in his first one hundred days in office at also said the federal emergency management agency committed one billion dollars to support state vaccination sites including mobile sites to help reach more people in the current priority. Groups you're either reticent to come to hospitals or have difficulty reaching them that includes addressing current inequities in healthcare access that are having particularly devastating effects on people of certain racial and ethnic backgrounds who have been disproportionately affected by covid nineteen. Nunez smith said members of her task force whose job it is to advise about the best ways to address these disparities especially with respect to vaccination will be formed soon. We cannot beat the pandemic without making sure we execute a plan that reaches all communities. She said the. Us centers for disease control and prevention is integral to success on that front will linski biden's new pick to head. The nation's public health organization summarized the sobering covid nineteen situation in the us and the urgent need to vaccinate the public. Though most of the major metrics daily infections hospitalizations and deaths have been decreasing. Recently she said expanding safe and effective vaccination is the key to ending the covid nineteen pandemic and bringing our country back to health. That she noted does not mean following in the footsteps of the uk where health officials recently decided to delay the second dose of the current to dose vaccines in order to get more people. There i shot instead. Will linski reiterated. Cdc advice that people get their second dose twenty one or twenty eight days after their. I if it's the pfizer bio intech or moderna vaccine respectively. Cdc also strongly recommends that people not mix and match vaccines from the two companies found. She provided a deeper look at the latest understanding of the three sars. Cuvee two mutations that have been of concern of late first reported in the uk south africa and brazil respectively and have all since been found in us patients in a study published on bio archive a pre print server that releases scientific studies before they are peer reviewed vaccine maker madonna and its collaborators at the us national institute of allergy and infectious diseases reported that after testing antibodies generated by people vaccinated with its shot. It was confident that its vaccine protected against the uk end. South african variants the level of viral neutralizing activity was slightly lower against the south african version. But as foul she noted it is still well within the cushion of protection. you could diminish vaccine induced. Antibodies efficacy by a few. Fold and still be well within the protective range with the vaccine. Researchers are still studying the brazilian variant which was identified more recently. And don't know yet how strongly immune responses to that mutant are the more worrying problem. These mutants pose found. She said is that they may reduce the efficacy of drug treatments. Targeted at neutralizing. the virus. The south african strain in particular has changes in areas that current drugs target so scientists are keeping a close watch..

Andy slamet jeff zion Nunez smith white house cova brazil nunez smith Will linski one billion dollars two companies one million vaccines linski biden second dose first one hundred days white house covid this week uk first one hundred million people brazilian south africa
"bio intech" Discussed on Pat Gray Unleashed

Pat Gray Unleashed

07:19 min | 4 months ago

"bio intech" Discussed on Pat Gray Unleashed

"Triple eight. Nine hundred thirty three ninety-three also at pat unleashed on twitter. Bill gates talking to a believe. Jake tapper about first policy. The america first approach to receiving the vaccine. The president wants to take care of americans. Here's what bill gates thinks about that. President trump signed an executive order That prioritizes distribution of the vaccine to americans Before it goes to people in other countries it's not entirely clear how the order will achieve that. But what do you think of that. Strategy that approach that everyone in the united states should be vaccinated first and then the us should pivot or these private company should pivot to helping the rest of the world. Why we need help all of humanity here Know we want the world economy. Be going we want to minimize the deaths and You know the. The basic technology is a german company and so international sharon cooperation has been disruptive and a mistake during this entire pandemic so positive to ramp. Virtually all of the companies that have developed vaccines are. Us companies. pfizer did work with bio intech in germany. They developed it together. Madonna is a an american company. Johnson and johnson is an american company. Astrazeneca is an american company. All of these people have have developed these things. Here in america for the most part and also why wouldn't you focus on your own country first and then spread it out to the rest of the world just i mean unbelievable to me that the globalist mindset that we have a responsibility to take care of everybody before ourselves. I'm sorry. what are the instructions on an airline win the cabin depressurizes and the oxygen masks. Drop down from that panel above your head. What is a what is a flight attendant to put yours on first then assist your children put yours on first and then assist everybody else. So why is that. Why why do we have that instruction well so you can take care of somebody else because if you pass out. You're not going to be able to help your kids. are you going to be. They're going to be lost without you. So if the if the united states of america goes down who's going to help the rest of the world then who's going to take care of everybody else. You gotta take care of yourself. I get on solid footing and then we can go take care of the of the world like we always do. I mean who on this planet has ever offered more aid to everybody else than the united states. We are always the first. On the scene of every single disaster we give by far More charitable donations to the rest of the world in foreign aid and And in private citizen aid by far more than anybody in the world probably more than the rest of the world combined. I mean our charitable giving tops. Three hundred billion a year like thirty to fifty billion of that comes from the us government. The rest is from us corporations and private citizens we always take care of the rest of the world. I wonderful was bill gates when he stole the technology that made him a billionaire from zero oxen. Ibm he took the the the mouse from. I believe it was xerox. And i believe the operating system came from ibm and then he knew how to apply those. Two things xerox. Ibm didn't really know what they had available to. Them gates was smart enough to figure that out but he did take the technology from them when when the money started rolling in did he take care of everybody else i did. He start setting all that all that money to other people or did he become a billion. I the richest man in the world. I and then start his philanthropic adventures. Let's see the rest of this So we need to ramp up the capacity of all the vaccines There will be some additional ones approved in the months ahead. Easier to scale up to manufacturing Button also the. Us has benefited from other countries. Work here and we shouldn't entirely selfish and how we go forward that's us. We're selfish so in your view. America first as the president might call it. Not the right approach. And what a surprise that we'd stream idea that Everybody should die until we have a very last american vaccinated by that. Yeah that was the executive order that The trump signed everybody else in the world should die until we have every last american vaccinated then with everybody else dead. We won't have to distribute the vaccine to anybody. How ridiculous is this guy all. Does he have more so the idea that everybody should die. Until we have the very last american vaccinated. That's ardley the appropriate response. Yeah nobody's suggesting it either is the interesting thing about that. Nobody suggesting that everybody else in the world should die before they get the vaccine. I don't know i. I don't understand it i really don't understand it. We all wanna take care of everybody else if we can. We wanna help other other people. Give them a hand up instead of a handout. But again there is a concept that you take care of yourself first so that you're alive and around and healthy enough to offer assistance to the rest of the world. How did you not get as the third richest person on earth. And this guy's mr vaccine. He he believes Strongly vaccines vaccines should come in fact With the ability to sterilize women so that we can Accomplish zero population growth. One of his deals a lot of people don't know his. His father was at one point ahead of planned parenthood the head of planned parenthood. So he's a big zero population guy now. Speaking of the vaccine. This is kind of interesting. Apparently vacs vaccine people. The people have developed pfizer madonna..

America bill gates President trump bio intech Jake tapper Ibm Astrazeneca xerox pfizer Madonna twitter Johnson johnson germany us government gates pfizer madonna
"bio intech" Discussed on TIME's Top Stories

TIME's Top Stories

02:35 min | 4 months ago

"bio intech" Discussed on TIME's Top Stories

"Of this year at home in coventry where she has lived for sixty years she will receive a booster shot in twenty one days to ensure she has the best chance of being protected against the virus said nhs england in a statement. Keenan shot was administered by nurse. May parsons who said it was a huge honor to play a part in the saving day may originally from the philippine says worked in the nhs for the last twenty four years. William shakespeare the second person to receive the vaccine also at university hospital. Coventry was eighty one year old. William shakespeare named after the playwright. Shakespeare called the vaccine groundbreaking in a television interview tuesday morning. The patient's name provoked a round of good natured responses on social media. With many offering puns on works by the bard of avon nurses and care homeworkers while england is putting senior citizens at the front of the line for vaccines other regions of the uk are prioritizing health. Care workers just after eight am gmt. Sister joanna sloan a became the first person in northern ireland to receive. The vaccine at the royal victoria hospital in belfast. I've been waiting looking forward to it for so long and it feels great. It feels fantastic. Privileged said sloan who will be managing the belfast. Trust vaccination center care home worker creek at forty eight became one of the first people in wales to receive the vaccine a day after a wales reported. Two thousand covid nineteen cases in a single day for the first time the. Uk's medicines and healthcare products regulatory agency authorized the vaccine produced by pfizer and bio intech last week which was shown to be ninety five percent effective in preventing illness from covid nineteen and clinical trials. The uk government has placed orders for forty million doses of the vaccine enough for twenty million people. Last two separate courses are needed. The development comes as covid nineteen deaths continued to rise in the country and cases rise in parts of southern england including essex kent and london almost sixty thousand people have died after testing positive for covid nineteen so far in the uk the highest in europe and the fifth highest number in the world. This is an incredibly important moment on the march out of this pandemic but we've still got a long march to go. This winter said health secretary matt hancock in response to the first patients. Receiving their vaccine's tuesday..

William shakespeare nhs joanna sloan england Keenan coventry belfast parsons university hospital Uk philippine royal victoria hospital Coventry bio intech wales
Trump to sign 'America First' executive order on Covid-19 vaccines Tuesday

CRUSADE Channel Previews

00:28 sec | 4 months ago

Trump to sign 'America First' executive order on Covid-19 vaccines Tuesday

"Food and drug administration may approve the first vaccine from pfizer bio intech. As soon as friday. Coming up our sainted. Today today's the immaculate conception of the blessed virgin mary he saved her from sin before she was born at the moment of her conception in saint ends womb are quoted the day. Hold your eyes on. God leave the doing to him. That's all the doing you have to worry. About saint jane francis de chantal. You're listening to

Food And Drug Administration Pfizer Jane Francis De Chantal
"bio intech" Discussed on TIME's Top Stories

TIME's Top Stories

03:53 min | 4 months ago

"bio intech" Discussed on TIME's Top Stories

"Pfizer and bio. Intech say. They've won permission wednesday for emergency use of their covid nineteen vaccine in britain. The world's first corona virus shot that's backed by rigorous science and a major step toward eventually ending the pandemic. the move makes britain one of the first countries to begin vaccinating. Its population as it tries to curb. Europe's deadliest covid nineteen outbreak. Other countries aren't far behind the us. And the european union also are vetting. The pfizer shot along with a similar vaccine made by competitor. Moderna inc pfizer said it would immediately begin shipping limited supplies to the uk and has been gearing up for even wider distribution if given a similar nod by the us food and drug administration. A decision expected as early as next week but doses everywhere are scarce and initial. Supplies will be rationed until more is manufactured in the first several months of next year visor. Co albert birla called the uk decision. A moment we are focusing on moving with the same level of urgency to safely supply. A high quality vaccine around the world bore said in a statement while the uk has altered enough pfizer vaccine for twenty million people. It's not clear. How many will arrive. By year's end. And adding to the distribution challenges is that it must be stored at ultra cold temperatures two doses. Three weeks apart are required for protection first in line. The uk government says our frontline healthcare workers and nursing home residents followed by older adults british regulators. Also were considering. Another shot made by astrazeneca and oxford university but prime minister. Boris johnson has warned. We must i navigate a hard winter of restrictions to try to curb the virus until there's enough vaccine to go around. Every country has different rules determining when an experimental vaccine is safe and effective enough to use intense political pressure to be the first to roll out a rigorously. Scientifically tested shot colored the race in the us and britain even as researchers pledged to cut no corners and contrast china and russia have offered different vaccinations to their citizens ahead of late. Stage testing the shots made by us based pfizer and its german partner bio intech were tested in tens of thousands of people and while that study isn't complete early results suggest. The vaccine is ninety five percent effective at preventing mild to severe covid nineteen disease the company's told regulators that of the first one hundred seventy infections detected in study volunteers. Only eight were among people who'd received the actual vaccine and the rest had gotten a dummy shot. This is an extraordinarily strong protection. Dr uber sahin. A bio intex. Ceo recently told the associated press. The companies are reported. No serious side effects. Although vaccine recipients may experience temporary pain and flu-like reactions immediately after injections but experts caution that a vaccine cleared for emergency use is still experimental and the final testing must be completed still to be determined is whether the pfizer bio tech shots protect against people spreading the coronavirus without showing symptoms. Another question is how long protection lasts. The vaccine also has been tested in only a small number of children none younger than twelve. And there's no information on its effects in pregnant women.

pfizer Moderna inc britain us food and drug administratio uk albert birla lauren european union bio intech Boris johnson astrazeneca us Europe oxford university Dr uber sahin russia china the associated press
UK Authorizes Emergency Use of Pfizer-BioNTech COVID-19 Vaccine

TIME's Top Stories

03:53 min | 4 months ago

UK Authorizes Emergency Use of Pfizer-BioNTech COVID-19 Vaccine

"Pfizer and bio. Intech say. They've won permission wednesday for emergency use of their covid nineteen vaccine in britain. The world's first corona virus shot that's backed by rigorous science and a major step toward eventually ending the pandemic. the move makes britain one of the first countries to begin vaccinating. Its population as it tries to curb. Europe's deadliest covid nineteen outbreak. Other countries aren't far behind the us. And the european union also are vetting. The pfizer shot along with a similar vaccine made by competitor. Moderna inc pfizer said it would immediately begin shipping limited supplies to the uk and has been gearing up for even wider distribution if given a similar nod by the us food and drug administration. A decision expected as early as next week but doses everywhere are scarce and initial. Supplies will be rationed until more is manufactured in the first several months of next year visor. Co albert birla called the uk decision. A moment we are focusing on moving with the same level of urgency to safely supply. A high quality vaccine around the world bore said in a statement while the uk has altered enough pfizer vaccine for twenty million people. It's not clear. How many will arrive. By year's end. And adding to the distribution challenges is that it must be stored at ultra cold temperatures two doses. Three weeks apart are required for protection first in line. The uk government says our frontline healthcare workers and nursing home residents followed by older adults british regulators. Also were considering. Another shot made by astrazeneca and oxford university but prime minister. Boris johnson has warned. We must i navigate a hard winter of restrictions to try to curb the virus until there's enough vaccine to go around. Every country has different rules determining when an experimental vaccine is safe and effective enough to use intense political pressure to be the first to roll out a rigorously. Scientifically tested shot colored the race in the us and britain even as researchers pledged to cut no corners and contrast china and russia have offered different vaccinations to their citizens ahead of late. Stage testing the shots made by us based pfizer and its german partner bio intech were tested in tens of thousands of people and while that study isn't complete early results suggest. The vaccine is ninety five percent effective at preventing mild to severe covid nineteen disease the company's told regulators that of the first one hundred seventy infections detected in study volunteers. Only eight were among people who'd received the actual vaccine and the rest had gotten a dummy shot. This is an extraordinarily strong protection. Dr uber sahin. A bio intex. Ceo recently told the associated press. The companies are reported. No serious side effects. Although vaccine recipients may experience temporary pain and flu-like reactions immediately after injections but experts caution that a vaccine cleared for emergency use is still experimental and the final testing must be completed still to be determined is whether the pfizer bio tech shots protect against people spreading the coronavirus without showing symptoms. Another question is how long protection lasts. The vaccine also has been tested in only a small number of children none younger than twelve. And there's no information on its effects in pregnant women.

Pfizer Moderna Inc Britain Us Food And Drug Administratio UK Albert Birla European Union Bio Intech Boris Johnson Astrazeneca United States Europe Oxford University Dr Uber Sahin Russia China The Associated Press FLU
"bio intech" Discussed on TIME's Top Stories

TIME's Top Stories

03:53 min | 4 months ago

"bio intech" Discussed on TIME's Top Stories

"By lauren near guard. Pfizer and bio. Intech say. They've won permission wednesday for emergency use of their covid nineteen vaccine in britain. The world's first corona virus shot that's backed by rigorous science and a major step toward eventually ending the pandemic. the move makes britain one of the first countries to begin vaccinating. Its population as it tries to curb. Europe's deadliest covid nineteen outbreak. Other countries aren't far behind the us. And the european union also are vetting. The pfizer shot along with a similar vaccine made by competitor. Moderna inc pfizer said it would immediately begin shipping limited supplies to the uk and has been gearing up for even wider distribution if given a similar nod by the us food and drug administration. A decision expected as early as next week but doses everywhere are scarce and initial. Supplies will be rationed until more is manufactured in the first several months of next year visor. Co albert birla called the uk decision. A moment we are focusing on moving with the same level of urgency to safely supply. A high quality vaccine around the world bore said in a statement while the uk has altered enough pfizer vaccine for twenty million people. It's not clear. How many will arrive. By year's end. And adding to the distribution challenges is that it must be stored at ultra cold temperatures two doses. Three weeks apart are required for protection first in line. The uk government says our frontline healthcare workers and nursing home residents followed by older adults british regulators. Also were considering. Another shot made by astrazeneca and oxford university but prime minister. Boris johnson has warned. We must i navigate a hard winter of restrictions to try to curb the virus until there's enough vaccine to go around. Every country has different rules determining when an experimental vaccine is safe and effective enough to use intense political pressure to be the first to roll out a rigorously. Scientifically tested shot colored the race in the us and britain even as researchers pledged to cut no corners and contrast china and russia have offered different vaccinations to their citizens ahead of late. Stage testing the shots made by us based pfizer and its german partner bio intech were tested in tens of thousands of people and while that study isn't complete early results suggest. The vaccine is ninety five percent effective at preventing mild to severe covid nineteen disease the company's told regulators that of the first one hundred seventy infections detected in study volunteers. Only eight were among people who'd received the actual vaccine and the rest had gotten a dummy shot. This is an extraordinarily strong protection. Dr uber sahin. A bio intex. Ceo recently told the associated press. The companies are reported. No serious side effects. Although vaccine recipients may experience temporary pain and flu-like reactions immediately after injections but experts caution that a vaccine cleared for emergency use is still experimental and the final testing must be completed still to be determined is whether the pfizer bio tech shots protect against people spreading the coronavirus without showing symptoms. Another question is how long protection lasts. The vaccine also has been tested in only a small number of children none younger than twelve. And there's no information on its effects in pregnant women..

pfizer Moderna inc britain us food and drug administratio uk albert birla lauren european union bio intech Boris johnson astrazeneca us Europe oxford university Dr uber sahin russia china the associated press
"bio intech" Discussed on Science Rules! with Bill Nye

Science Rules! with Bill Nye

06:25 min | 5 months ago

"bio intech" Discussed on Science Rules! with Bill Nye

"This is going to be a multi year fight. why is it taking so long to get a screening test. It is not a hoax israel. Something that we have never experienced before wash hands wash hands wash and scientists are gonna tell me welcome. Welcome to science rules. Karuna virus edition. I'm your host bill nye and this is the series that brings you the latest analysis and the science of this pandemic to keep you informed prepared and calm. We are still all in this together. My friends as early monday. More than twelve million people in the us have been infected with the coronavirus with more than a million new infections in the last week and more than a quarter of a million deaths since january as the new york times pointed out. That's roughly the population of richmond. Virginia or fort wayne indiana or saint petersburg florida madison wisconsin scottsdale arizona reno nevada buffalo new york and you get the grim picture people and in case someone tells you oh everyone else's handling this just as poorly as way are great. That's also more than eighteen percent of all cova related deaths worldwide far more than are proportional share the. Us kinda sucks at this with a new president coming into office in january. Good news about vaccines on the way and bad news about infection surges. Before the holidays. There's a lot to take in right now here to help explain it. All is none other than dr tool gandhi. He's a surgeon author of books like the checklist manifesto and being more and for us today. His a member of president elect joe biden's new covid nineteen advisory board. Dr tool gandhi welcomed science rules. Corona virus. edition may call you tool. Yes i was going to say. I'm a huge fan bill. And i look forward to this podcast and the chance to meet you a while really it so this is electrostatic meeting. Everybody we are. It is fantastic distant but everybody wonders about the advisory board. How'd you guys meet is a virtual. Do you go to a room. You get tested or you're wearing masks go ahead. It's entirely virtual and it's thirteen really great people from Wide range of backgrounds from the person. Rick bright who got fired from barreda the i o medical advanced research and development which is the research agency that was behind vaccines and and rick ripe got in trouble for telling the truth and saying hydroxychloroquine wasn't going to be something that they recommended spending an enormous amount of money on because the data wasn't there while this is a group of folks who are coming from all kinds of backgrounds healthcare scientists and public health and so on and i just feel really lucky to be among them and you know we are plugging into a transition which is a sort of fake transition not a fake transition but it's a transition in transition we don't have an administration that has admitted yet that we can meet with agency officials to be ready on january twenty. I am a taxpayer and citizen. I'm voter what in the world is going on. So there was a coronavirus taskforce force. Did they accomplish much of anything and then are you able to speak with them. And so on wealth there are important things that career scientists everywhere from the cdc to the fda to barda to the nih national institutes of health have been doing that from Driving discoveries around testing driving basic facts and understanding about the virus Public health advice and guidance and then being part of creating driving new vaccines and tests and therapeutics. All of those people. There are many of them. They've been hard at work but There is a political administration that decides. Are we supporting those people. Do we put them forward and a lot of the public health. Wanna one basics. Are you put the scientists forward and when the facts aren't politically convenient. You You nonetheless recognize the scientists and doctors and experts and let them come forward. And and that's that's been a challenge as you now challenge a challenge. Put roughly. I got a couple of questions but put roughly. Is anything going to happen before january twentieth. Well i fully believe it will but it is extraordinary. I didn't interview the other day. Where dr fauci was on and then i followed and that was the only interaction. That's the closest kind of interaction. We're allowed to have at present. The reality is there some really fundamental things that need to happen right now We have a amazing news. As of today that we now have three effective vaccines According to preliminary data from the clinical trials you can you list them. Forward short head So number one is the pfizer Bio intech 'em aren a based vaccine that vaccine trial has now been completed and submitted their data to the fda approval and they found ninety five percent effectiveness in preventing infections of from the coronavirus. Now then madonna has also got an m. r. m. a. based vaccine and they also had ninety five percent effectiveness which is a remarkably high level of effectiveness. Lets hope that holds up in the months to come as they continue to follow these folks how. I think we all been intuition. How compares to a an influenza vaccine which is like fifty percent effective. Does that compare to polio. Vaccine for example. Yeah i don't have the numbers on the vaccine levels that are between there but this is among the highest right. So you you've rightly got the the range. The flu vaccine can be as low as twenty five percent effectiveness in a given year off around fifty percent. Then you'll have a vaccine is like the measles vaccine and Ebola.

flu vaccine president advisory board bill nye new york times Dr tool gandhi israel influenza richmond new york joe biden pfizer Bio intech Virginia cdc dr fauci Rick bright fda rick ripe nih
"bio intech" Discussed on TIME's Top Stories

TIME's Top Stories

03:02 min | 5 months ago

"bio intech" Discussed on TIME's Top Stories

"Pfizer's ceo and chairman albert birla announced that the company has filed a request to the us food and drug administration for emergency use authorization of its covid. Nineteen vaccine making it the first to do so and a discussion on time. One hundred talks borlase says that. If the fda authorizes the vaccine the company will be ready within hours from receiving the green light to start distributing the vaccine. Pfizer has been manufacturing doses. Even wild safety and efficacy tests were ongoing in order to avoid delays in shipping wants authorized according to bora pfizer is on track to deliver the fifty million doses promised to the us government by the end of the year with one point three billion doses through year in an in depth conversation about the journey. The company has taken in developing its vaccine borel emitted that throughout the process. He wasn't always sure that having a safe and effective vaccine ready for fda review in less than a year was possible. Conviction is a part of it. So i was always telling our teams that we will make it and we will make it by october and if not us then who he says but i knew that it wasn't extremely risky suggestion. I knew it was going to be difficult. And the stars needed to be aligned. All the way to the end. Pfizer capitalized on a partnership begun. Twenty with german company bio intech which was founded by a husband and wife team of scientists with expertise in genetic technology called 'em aren a platform is fast and flexible for developing vaccines. Since it only requires knowing the genetic sequence of the virus the vaccine will target rather than growing and manipulating the virus. In question still. No 'em are in a based vaccine against an infectious disease had ever been approved so pfizer and bio intech began exploring whether influence might be the first instead when the pandemic hit a year later. The teams shifted their attention to sars covy to the novel corona virus. That causes covid nineteen with surprising. Success borlase says the partnership is built on a mutual focus on advancing science and the two companies began work including sharing confidential information before signing a formal contract since those agreements can take months in fact we are still finalising the contractual obligations. We have that we need to sign with them says paula. It's the perfect relationship for me to her. Shaheen bio and co founder and chief executive is a wonderful human being and a great scientist. He shares the same passion as i do about saving lives. And i'm very optimistic. That not only will we do very well together. Bringing a covid nineteen vaccine to the world but later hopefully a flu vaccine orla also believes the success of the pfizer biotech vaccine as well as that of massachusetts based biotech moderna which also has an m..

Pfizer borlase flu vaccine us fda albert birla paula Shaheen bio ceo chairman massachusetts scientist co founder chief executive
"bio intech" Discussed on Wall Street Breakfast

Wall Street Breakfast

02:18 min | 5 months ago

"bio intech" Discussed on Wall Street Breakfast

"Leading. Today's news vaccine euphoria that propel stocks to record highs is wearing off as traders focus on a surge in corona virus transmission rates in the us or deaths from the illness surpassed two hundred and fifty thousand. According to johns hopkins university. The number of fatalities has remained above thousand a day for eight of the past. Nine days a tally that was last seen in late. August sentiment was particularly dented. After new york city's shed schools and switch to fully remote learning for its students because of surging cases of covid nineteen us stock index futures fell point four percent overnight on the news after bouncing around the flat line for most of wednesday only to turn south in the final hour of trading chances of stimulus from washington are also dim as lawmakers remained deadlocked over the size of a corona virus aid package in other news. Some positive news was still seen overnight. After a jab from the university of oxford which is working in collaboration with astrazeneca shown to have generated a robust immune response and adults in their sixties and seventies preliminary results revealed that the vaccine chid o x one in nineteen prompted. What's known as a t. Cell response within fourteen days of the first dose as well as an antibody response within twenty eight days of a booster dose. We hope that this means our vaccine will help to protect some of the most vulnerable people in our society said dr mahachi ram asami a co author of the study at the university of oxford phase. Three trials of the vaccine are still ongoing with early. Efficacy readings possible in the coming weeks with pfizer and bio intech having concluded there phase three study of their covid nineteen vaccine candidate which showed a success rate of ninety five percent and no serious adverse events. The drug might be headed to securing evidence. Use approval next month. If all those well. I could imagine that we gain approval in the second half of cimber and start deliveries before christmas but really only if all goes positively bio intech ceo. You're signing told reuters. Tv storage and distribution is still complicated. Pfizer's vaccine must be.

university of oxford Pfizer johns hopkins university reuters new york city intech washington ceo
"bio intech" Discussed on America Off The Rails

America Off The Rails

01:38 min | 5 months ago

"bio intech" Discussed on America Off The Rails

"Bio intech announced wednesday that after the completion of the phase. Three trial of their coronavirus vaccine. It was found to be ninety. Five percent effective without serious safety concerns observed visor says they will ask the food and drug administration for an emergency use approval at the end of the week health and human services secretary. Alex as our says the pfizer moderna vaccine should be ready to go by the end of the year by the end of december. We expect to have about forty million doses of these two vaccines available for distribution. That's good news coming on a grim day in the pandemic as the country passes two hundred and fifty thousand confirmed deaths from cova. There was an average of one thousand one hundred sixty seven deaths from the disease per day last week. Another seventy seven thousand. Americans remain hospitalized with the disease. This is usa radio news. The legal team for president. Trump's campaign is continuing legal challenges this week contesting issues with the presidential election in several states while the outcome of these cases is still pending. Many republicans have been calling for investigations into a number of accusations of voting irregularities and fraud senator. Mike bronze says it's in the nation's best interest to look into those claims. The indiana republican told reporters on wednesday that it's important to go through all of the process. You know in terms of the evidence. I think it's going to be important. We take the time to make sure if it's out there we find. It goes back to what i said earlier and less. That's done thoroughly. And i think there are signs of it whether it's going to be enough to make any difference in the outcome. That's what the process is about. I think the president has the right to pursue it to the fullest extent..

president Bio intech pfizer moderna cova contesting Mike bronze indiana usa Alex Trump secretary fraud senator
"bio intech" Discussed on TIME's Top Stories

TIME's Top Stories

01:46 min | 5 months ago

"bio intech" Discussed on TIME's Top Stories

"Nine hundred fifty five of the total forty. Three thousand five hundred thirty eight volunteers enrolled. Pfizer is the first company to release results from its covid. Nineteen vaccine part of a plant interim analysis by an independent data safety monitoring board that is reviewing all of the handful of vaccine candidates from different companies that are currently being tested and people. The findings represent results collected seven days. After the second of pfizer's to shot regimen visor which developed and tested its vaccine with german company bio intech said in a release that it will continue to follow people in the study for a couple more weeks until the middle of november. When everyone in the study will happen followed for at least two months. That's the timeframe the food and drug administration is requiring for covid nineteen vaccines before considering them for emergency authorization or approval. The results represent a victory. Not only for public health but for science as well. The company's vaccine is based on a new technology. That relies on a genetic material. Known as m are in a no ima- rene based vaccines have received approval from the fda yet although several are being tested for other diseases. The results are a testament to the benefits of the platform. Using 'em are in a speeds up development of a vaccine since the process does not require growing vast amounts of virus instead vaccine developers only needed the genetic sequence of sars covy to which became available in january to start building a vaccine other companies including massachusetts based moderna and vaccine giant. Sanofi are also testing. 'em are in a covid nineteen vaccines..

pfizer massachusetts intech fda ima
"bio intech" Discussed on Heartland Newsfeed Radio Network

Heartland Newsfeed Radio Network

02:25 min | 8 months ago

"bio intech" Discussed on Heartland Newsfeed Radio Network

"Eighty, six, thirty, eighty, six, eighty, six years old and. He's still going at it. Now we have we just got news a Hashtag reawakened Aizie, which is Arizona Hashtag reopen as e it's a rock and roll and whatnot I got. A email from rick here in Michigan he's going you know what you need to do Redding. California was selected to participate in both. Modern 'em a twelve, seventy three and a Pfizer Bio INTECH forthcoming phased namdeb that clinical trials I might have a contact for me the over going to they're going to they're they're they're going to hard plough on this fourth vaccination of Uganda and we're GonNa make you had fallen in your you know later years. Covert might be a thing for you. You got a compromised immune system, but I don't know you for four should be my grandkids. Take back scene for you steven what your opinion. Oh. Absolutely not and no. No one will force me to take vaccine. I will not make it if I do have closer to the microphone you're really low. Well. Okay. Out that. Is that better better you? I will not take vaccine, I know the toxic the Cova vaccines, the development is being very rushed. Normally vaccines take four or five years to develop most trials fail of small percentage succeed, and even the ones that succeed have had problems associated with them. I've written a great deal about this quoting I'm not a vaccine expert but I've quoted. Experts I know the world's leading at least one of the world's leading vaccines experts the Schreider. When I had my radio program I had to run twice. She's from Australia. So she has come on in the middle of the night which she did. She she absolutely unequivocally says, stay away from vaccines but vaccine who's been developed an in a short period of time six months or so here is no possibility in the world it is it is safe to use anybody taking this vaccines will be playing Russian roulette with their health. If that's what somebody wants to do I have no argument with it it's their choice. It's an individual choice nobody in government or anyplace else should force anybody to do what they don't want to do especially when it relates to the healthier and we agree.

rick Pfizer Bio INTECH Arizona Uganda Redding California Australia Schreider Michigan
"bio intech" Discussed on NPR News Now

NPR News Now

04:28 min | 9 months ago

"bio intech" Discussed on NPR News Now

"From NPR news I'm Shay Stevens. California now leads the nation with the most confirmed cases of the new corona virus NPR's Eric. Westervelt reports at the state hit a single day high for new infections on Wednesday, the first state to lockdown. California successfully stalled the spread of the virus this spring, but cases have steadily grown since late May. When many cities and counties started to reopen restaurants, an indoor shopping and California just reported more than twelve, thousand, eight hundred new confirmed cases a record one day increase, governor, Gavin Newsom, a sober reminder of why we are taking things as seriously as we are sober reminder. Of why we put in that mask mandate, the rise recently prompted newsom to retreat on reopening, ordering the closure of all bars and indoor dining statewide, and in most of the state gyms, malls and hair salons Eric. Westervelt NPR news Berkeley. US Health and Human Services. Secretary Alex as our says five potential corona virus vaccines currently under development. He says the government has reached an agreement to pay Pfizer and German company BIO INTECH two billion dollars for one hundred million doses of covert nineteen vaccine by the end of the year. A trump administration program seeks to have multiple vaccines available for distribution wants the FDA approved them. Or for emergency use following clinical trials. Has just passed its most significant piece of environmental legislation in decades to provide funding for national parks and land conservation as NPR's Nathan Ross reports. The Great American outdoors act is headed to President Trump's desk for his signature. It's been a while since the country's national parks, wildlife refuges in public lands got a big infusion of federal funding and in a lot of places, it shows campgrounds in disrepair. pothole pitted roads. Shudder visitor centers the Great. American, OUTDOORS ACT EARMARKS BILLIONS OF DOLLARS to address those maintenance backlogs at least in part, and it provides permanent funding to a program, called the land and Water Conservation Fund which helps fund outdoor recreation and access to the outdoors. The timing of the bill's passage is not accidental. President trump is aiming to give credit for its passage to two Republican senators in Montana and Colorado who are in tight races for reelection. Reelection Nathan NPR news. A Canadian judge has struck down the country safe third country agreement with the U. S. as Dan Carpenter Chuck report. It's a policy. The two countries used to deal with asylum seekers. The agreement means that Canada, the US recognize each other a safe countries for refugees, those who land in the US, and then try to seek asylum in Canada are turn back because they must make that claim in the country in which they first arrived, but the Canadian judge ruled, refugees deemed ineligible in the US face detention or other rights abuses that she says violates their Constitutional Rights Dan Carpenter. Reporting this is NPR news. Oregon's governor seeking restraining order against federal agents in Portland State officials allege the officers are using unmarked cars and excessive force to make unwarranted arrests of protesters, the Department of Homeland Security says the officers were sent to the city to protect government property. A federal judge is weighing arguments over the issue. Human Rights Watch is warning about political attacks in Guatemala as Maria Martin reports, the advocacy group says the country's human rights ombudsman could be dismissed for defending lgbtq rights in the country. Their livelihood to make it better for others did he began organizing? Sit Ins in the nineteen forties against segregation in Illinois where he lived. He joined Martin Luther, King Junior in the earliest days of what became the Civil Rights Movement, twenty five points, and the S&P five hundred edit eighteen. In pre-market trading, US futures are mixed at this hour on Asian stock market shares are mixed. Higher in Hong Kong? I'm Shay Stevens this. Is NPR news..

NPR US California Shay Stevens Dan Carpenter Trump Nathan NPR Gavin Newsom Eric President Alex Westervelt Civil Rights Movement Martin Luther Department of Homeland Securit Hong Kong Canada
Pfizer, BioNTech Get Covid-19 Vaccine Order From U.S. Government

NPR News Now

00:29 sec | 9 months ago

Pfizer, BioNTech Get Covid-19 Vaccine Order From U.S. Government

"Health and Human Services. Secretary Alex as our says five potential corona virus vaccines currently under development. He says the government has reached an agreement to pay Pfizer and German company BIO INTECH two billion dollars for one hundred million doses of covert nineteen vaccine by the end of the year. A trump administration program seeks to have multiple vaccines available for distribution wants the FDA approved them. Or for emergency use following clinical trials.

Alex Bio Intech Secretary Pfizer FDA